Abstract
Purpose: Hyperthyroidism results in free radical production and this free radical production results in cell damage. Melatonin, which is an effective hormone in the management of the metabolism, prevents the harmful effects of free radicals like nitric oxide via its direct antioxidant effect. This study was conducted to investigate the role of nitric oxide in experimental hyperthyroidism and the effect of melatonin on nitric oxide.
Materials and Methods: Thirty Wistar Albino female rats were randomized into three groups: Group A (negative control group) underwent saline injection; Group B (positive control group) underwent intraperitoneal L-Thyroxine 0.2 mg/kg/day and Group C (treatment group) underwent intraperitoneal L-Thyroxine 0.2 mg/kg/day + melatonin 3 mg/kg/day. After 3 weeks, all rats were decapitated and blood, liver and heart tissue samples were taken. Biochemically, FT3, FT4, TSH and NO levels were investigated.
Results: There was a significant change in FT3 levels between Groups A and B, and Groups B and C (p<0.001 and p=0.004, respectively). Concerning FT4 levels, there was a significant change between Groups A and B and Groups A and C (p<0.001 and p=0.02 respectively). Changes in median blood NO levels of Group A, B and C were significantly different (5,93 μM/L; 48,41 μM/L and 42,69 μM/L, respectively) (p<0.001). Heart NO level of Group B is similar to Group A (1,74 µmol/g vs. 1,74 µmol/g). There was also no statistically significant difference between Group B and C, although heart levels decreased in Group C (1,25 µmol/g), (p=0,05). Liver NO levels showed a significant difference between Group A and B, while there was no significant difference between Groups B and C (0,30 µmol/g; 0,46 µmol/g ve 0,41 µmol/g, respectively).
Conclusion: Results of this study should be confirmed with future studies conducted with different doses and application time intervals of melatonin. We believe that these future studies will lead melatonin to a major role in the fight against pathologies like hyperthyroidism that affect many systems.
Keywords:
Hyperthyroidism, nitric oxide, melatonin, free oxygen radicals
References
1Asayama K, Kato K. Oxidative muscular injury and its relevance to hyperthyroidism. Free Radic Biol Med 1990;8:293-303.
2Venditti P, Di Meo S. Thyroid hormone-induced oxidative stress. Cell Mol Life Sci 2006;63:414-434.
3Yazıcı C, Köse K. Melatonin: karanlığın antioksidan gücü. Erciyes Üniversitesi Sağlık Bilimleri Dergisi 2004;13:56-65.
4Halliwell B, Gutteridge JMC. Free radicals in biology and medicine 2nd ed. Clarendon Press, Oxford 1996;10-19:86-130.
5Valentine JS, Wertz DL, Lyons TJ. The dark side of dioxygen biochemistry. Curr Opin Chem Biol 1998;2:253-262.
6Hardeland R, Reiter RJ, Poeggeler B, et al. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 1993;17:347-357.
7Brusco LI, Marquez M, Cardinali DP. Monozygotic twins in Alzheimer's disease treated with melatonin: case report. J Pineal Res 1998;25:260–263.
8Gitto E, Karbownik M, Reiter RJ. Effects of melatonin treatment in septic newborns. Pediatr Res 2001;50:756–760.
9Fulia F, Gitto E, Cuzzocrea S. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns. J Pineal Res 2001;31:343-349.
10Mogulkoc R, Baltacı A, Öztekin E, et al. Melatonin prevents oxidant damage in various tissues of rats with hyperthyroidism. Life Sci 2006 ;79:311-315
11Venditti P, Balestrieri M, Di Meo S, et al. Effect of thyroid state on lipid peroxidation, antioxidant defences, and susceptibility to oxidative stress in rat tissues. J Endocrinol 1997; 155:151-157.
12Venditti P, De Rosa R, Di Meo S. Effect of thyroid state on susceptibility to oxidants and swelling of mitochondria from rat tissues. Free Radic Bio Med 2003;35:485-494.
13Baydas B, Meral I. Effects of melatonin on lipid peroxidation and anti-oxidant enzyme activity in rats with experimentally induced hyperthyroidism. Clin Exp Pharmacol Physiol 2005;32:541-544.
14Fernandez V, Cornejo P, Tapia G, et al. Influence of hyperthyroidism on the activity of liver nitric oxide synthase in the rat . Nitric Oxide 1997;6:463-468.
15Bianchi G, Solaroli E, Zaccheroni V, et al. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm Metab Res 1999;31:620-624.
16Abalovich M, Llesuy S, Gutierrez S, et al. Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments. Clin Endocrinol. 2003;59:321-327.
17Resch U, Helsel G, Tatzber F, et al. Antioxidant status in thyroid dysfunction. Clin Chem Lab Med 2002;40:1132-1134.
18Curran RD, Billiard TR, Stuehr DJ, et al. Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells. J Exp Med 1989;170:1769-1774.
19Billiard TR, Curran RD, Stuehr DJ, et al. Evidence that activation of Kupffer cells results in the production of L-arginine metabolites that release cell-associated iron and inhibit hepotocyte protein synthesis. Surgery 1989;106:364-372.
20Ignarro LJ. Nitric oxide: biology and pathobiology, Academic Press, San Diego 2000.
